Cancer Drug Trametinib Shrinks Oral Tumors in Dogs, Trial Shows
A Cornell clinical trial found that the oral MEK inhibitor trametinib shrank or stabilized oral squamous cell carcinoma tumors in ...
A Cornell clinical trial found that the oral MEK inhibitor trametinib shrank or stabilized oral squamous cell carcinoma tumors in ...
A new study shows that the developmental transcription factor PAX9 acts as a tumour suppressor in oral squamous cell carcinoma ...
A new mouse study finds that combining the PARP inhibitor olaparib with radiotherapy improves tumor control in oral squamous cell ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine